N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole

C125H137F4N17O11 — CID 159527907

IUPACN-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole
SMILESCOc1cc(-c2noc3c2CCCC3(O)c2cc(C)cc(F)c2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3CCc2cc(C)cc(F)c2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3C[C@H](C)c2ccc(C)cc2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3NC2CCCCC2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3NCC(C)(F)F)ccc1-n1cnc(C)c1
InChIInChI=1S/C28H31N3O2.C27H28FN3O2.C25H24FN3O3.C24H30N4O2.C21H24F2N4O2/c1-18-8-10-21(11-9-18)19(2)14-23-6-5-7-24-27(30-33-28(23)24)22-12-13-25(26(15-22)32-4)31-16-20(3)29-17-31;1-17-11-19(13-22(28)12-17)7-8-20-5-4-6-23-26(30-33-27(20)23)21-9-10-24(25(14-21)32-3)31-15-18(2)29-16-31;1-15-9-18(12-19(26)10-15)25(30)8-4-5-20-23(28-32-24(20)25)17-6-7-21(22(11-17)31-3)29-13-16(2)27-14-29;1-16-14-28(15-25-16)21-12-11-17(13-22(21)29-2)23-19-9-6-10-20(24(19)30-27-23)26-18-7-4-3-5-8-18;1-13-10-27(12-25-13)17-8-7-14(9-18(17)28-3)19-15-5-4-6-16(20(15)29-26-19)24-11-21(2,22)23/h8-13,15-17,19,23H,5-7,14H2,1-4H3;9-16,20H,4-8H2,1-3H3;6-7,9-14,30H,4-5,8H2,1-3H3;11-15,18,20,26H,3-10H2,1-2H3;7-10,12,16,24H,4-6,11H2,1-3H3/t19-,23?;;;;/m0..../s1
InChIKeyMCPPGCBSLZIXEH-MVOMFLMISA-N
MW2129.57 g/mol
LogP27.59
Rot. Bonds27

About N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole

N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole (PubChem CID 159527907) has the molecular formula C125H137F4N17O11 and a molecular weight of 2129.57 g/mol. Its IUPAC name is N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole.

Molecular Properties

Compound NameN-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole
PubChem CID159527907
Molecular FormulaC125H137F4N17O11
Molecular Weight2129.57 g/mol
Exact Mass2128.06
IUPAC NameN-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole
SMILESCOc1cc(-c2noc3c2CCCC3(O)c2cc(C)cc(F)c2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3CCc2cc(C)cc(F)c2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3C[C@H](C)c2ccc(C)cc2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3NC2CCCCC2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3NCC(C)(F)F)ccc1-n1cnc(C)c1
InChIInChI=1S/C28H31N3O2.C27H28FN3O2.C25H24FN3O3.C24H30N4O2.C21H24F2N4O2/c1-18-8-10-21(11-9-18)19(2)14-23-6-5-7-24-27(30-33-28(23)24)22-12-13-25(26(15-22)32-4)31-16-20(3)29-17-31;1-17-11-19(13-22(28)12-17)7-8-20-5-4-6-23-26(30-33-27(20)23)21-9-10-24(25(14-21)32-3)31-15-18(2)29-16-31;1-15-9-18(12-19(26)10-15)25(30)8-4-5-20-23(28-32-24(20)25)17-6-7-21(22(11-17)31-3)29-13-16(2)27-14-29;1-16-14-28(15-25-16)21-12-11-17(13-22(21)29-2)23-19-9-6-10-20(24(19)30-27-23)26-18-7-4-3-5-8-18;1-13-10-27(12-25-13)17-8-7-14(9-18(17)28-3)19-15-5-4-6-16(20(15)29-26-19)24-11-21(2,22)23/h8-13,15-17,19,23H,5-7,14H2,1-4H3;9-16,20H,4-8H2,1-3H3;6-7,9-14,30H,4-5,8H2,1-3H3;11-15,18,20,26H,3-10H2,1-2H3;7-10,12,16,24H,4-6,11H2,1-3H3/t19-,23?;;;;/m0..../s1
InChIKeyMCPPGCBSLZIXEH-MVOMFLMISA-N
XLogP27.59
TPSA309.69 Ų
H-Bond Donors3
H-Bond Acceptors28
Rotatable Bonds27
Heavy Atoms157
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002129.57
LogP ≤ 527.59
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1028

Analyze N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1,2-Benzisoxazol-7-aMine, N-(4-fluorophenyl)-4,5,6,7-tetrahydro-3-[3-Methoxy-4-(4-Methyl-1H-iMidazol-1-yl)phenyl]-
CID 71552188
N-[(1R)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine
CID 71557500
N-(3,5-difluorobenzyl)-3-(3-Methoxy-4-(4-Methyl-1H-iMidazol-1-yl)phenyl)-4,5,6,7-tetrahydrobenzo[d]isoxazol-7-aMine
CID 71557501
7-(3,5-difluorophenyl)-3-(3-Methoxy-4-(4-Methyl-1H-iMidazol-1-yl)phenyl)-4,5,6,7-tetrahydrobenzo[d]isoxazol-7-ol
CID 71557502
N-[(4-fluorophenyl)methyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine
CID 89554314
7-[(3,5-difluorophenyl)methyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol
CID 89554316
N-[1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine
CID 78111023
7-[(3-fluoro-5-methylphenyl)methyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol
CID 117620143
7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol
CID 117620145
1-(3,3-difluoro-4-propan-2-yl-2H-1-benzofuran-7-yl)-4-methylimidazole;1-(2-ethoxy-4-propan-2-ylphenyl)-4-ethylimidazole;3-methyl-7-(4-methylimidazol-1-yl)-4-propan-2-yl-1,2-benzoxazole;4-methyl-1-(5-propan-2-yl-2-bicyclo[4.2.0]octa-1,3,5-trienyl)imidazole;4-methyl-1-(4-propan-2-yl-2,3-dihydro-1-benzofuran-7-yl)imidazole;4-methyl-1-(4-propan-2-yl-2-propoxyphenyl)imidazole
CID 157306707
N-(cyclopropylmethyl)-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazol-3-amine;3-imidazol-1-yl-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazole;N-[(6-methyl-2-pyridinyl)methyl]-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazol-3-amine;3-morpholin-4-yl-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazole
CID 159188292
N-(cyclopropylmethyl)-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazol-3-amine;N,N-dimethyl-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazol-3-amine;3-imidazol-1-yl-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazole;N-[[(2R)-5-methylidenepyrrolidin-2-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazol-3-amine;N-[(6-methyl-2-pyridinyl)methyl]-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazol-3-amine;3-morpholin-4-yl-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazole;N-propan-2-yl-5-[4-(trifluoromethoxy)phenyl]-1,2-benzoxazol-3-amine
CID 159262421

Frequently Asked Questions

What is the IUPAC name of N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole?
The IUPAC name of N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole (CID 159527907) is N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole.
What is the SMILES notation for N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole?
The canonical SMILES for N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole is COc1cc(-c2noc3c2CCCC3(O)c2cc(C)cc(F)c2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3CCc2cc(C)cc(F)c2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3C[C@H](C)c2ccc(C)cc2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3NC2CCCCC2)ccc1-n1cnc(C)c1.COc1cc(-c2noc3c2CCCC3NCC(C)(F)F)ccc1-n1cnc(C)c1.
What is the InChIKey of N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole?
The InChIKey is MCPPGCBSLZIXEH-MVOMFLMISA-N. The full InChI is InChI=1S/C28H31N3O2.C27H28FN3O2.C25H24FN3O3.C24H30N4O2.C21H24F2N4O2/c1-18-8-10-21(11-9-18)19(2)14-23-6-5-7-24-27(30-33-28(23)24)22-12-13-25(26(15-22)32-4)31-16-20(3)29-17-31;1-17-11-19(13-22(28)12-17)7-8-20-5-4-6-23-26(30-33-27(20)23)21-9-10-24(25(14-21)32-3)31-15-18(2)29-16-31;1-15-9-18(12-19(26)10-15)25(30)8-4-5-20-23(28-32-24(20)25)17-6-7-21(22(11-17)31-3)29-13-16(2)27-14-29;1-16-14-28(15-25-16)21-12-11-17(13-22(21)29-2)23-19-9-6-10-20(24(19)30-27-23)26-18-7-4-3-5-8-18;1-13-10-27(12-25-13)17-8-7-14(9-18(17)28-3)19-15-5-4-6-16(20(15)29-26-19)24-11-21(2,22)23/h8-13,15-17,19,23H,5-7,14H2,1-4H3;9-16,20H,4-8H2,1-3H3;6-7,9-14,30H,4-5,8H2,1-3H3;11-15,18,20,26H,3-10H2,1-2H3;7-10,12,16,24H,4-6,11H2,1-3H3/t19-,23?;;;;/m0..../s1.
What are the key properties of N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole?
N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole has a molecular weight of 2129.57 g/mol, XLogP of 27.59, 27 rotatable bonds, 3 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclohexyl-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;N-(2,2-difluoropropyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazol-7-amine;7-[2-(3-fluoro-5-methylphenyl)ethyl]-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,2-benzoxazole;7-(3-fluoro-5-methylphenyl)-3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-5,6-dihydro-4H-1,2-benzoxazol-7-ol;3-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-7-[(2S)-2-(4-methylphenyl)propyl]-4,5,6,7-tetrahydro-1,2-benzoxazole is sourced from PubChem (CID 159527907), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).